Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood-Brain Barrier Permeability Quantification in Cerebral Small Vessel Disease -- Reproducibility of Dynamic Contrast-enhanced MRI

NCT02033291 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02033291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02033291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood-Brain Barrier Permeability Quantification in Cerebral Small Vessel Disease -- Reproducibility of Dynamic Contrast-enhanced MRI
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
October 31, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood-brain barrier permeability, cerebral hemorrhage, cerebral small vessel disease, cortical stroke